| LZ ALPHA | FRI · SEP 4, 2026 · 06:00 EST · ISSUE #246 |
The overnight tape is disclosure-heavy but signal-thin: Congress gave us one big historical filing from Sept. 1 plus a few smaller Sept. 2 updates, while the insider and 8-K feeds are current to Sept. 3. The sharpest read-through is dilution and balance-sheet risk in SEC filings, with insider conviction concentrated in just a handful of true open-market buys.
| Type | Ticker | Signal | Flagged | Then | Now | Return |
|---|---|---|---|---|---|---|
| 8-K | CLMT | Calumet, Inc. /DE | 2026-09-02 | $49.73 | $53.50 | ▲ 7.6% |
| 8-K | OKE | ONEOK INC /NEW/ | 2026-09-01 | $96.01 | $95.75 | ▼ 0.3% |
| 8-K | CHRS | Coherus Oncology, Inc. | 2026-08-29 | $1.46 | $1.37 | ▼ 6.2% |
The filing shows four partial stock sales: two NVDA sales, one LRCX sale and one AMGN sale, with the largest NVDA line at $15,001 - $50,000.
The signal is trimming high-profile AI and semiconductor exposure after a powerful tape for the group. The filing was made within the required window, so the market read is positioning rather than compliance risk.
| NVDA | Sell | STOCK | $15,001 - $50,000 |
| LRCX | Sell | STOCK | $1,001 - $15,000 |
| NVDA | Sell | STOCK | $1,001 - $15,000 |
| AMGN | Sell | STOCK | $1,001 - $15,000 |
The filing contains two spouse trades on Aug. 18: a purchase of NVDA stock and a partial sale of AAPL stock, each in the $1,001 - $15,000 range.
Small dollars, but the rotation is clean: reduce Apple, add NVIDIA. It keeps congressional attention on the AI trade, even though the position size is modest.
| NVDA | Buy | STOCK | $1,001 - $15,000 |
| AAPL | Sell | STOCK | $1,001 - $15,000 |
Rulli reported a full sale of ALL stock and a purchase of EQIX stock, each in the $1,001 - $15,000 range.
The filing is small, but the sector pivot is notable: out of insurance and into data-center real estate. EQIX is a cleaner AI-infrastructure proxy than the more crowded mega-cap semiconductor names.
| ALL | Sell | STOCK | $1,001 - $15,000 |
| EQIX | Buy | STOCK | $1,001 - $15,000 |
The filing is one purchase of AAPL common stock on Aug. 13 in the $1,001 - $15,000 range.
It is a clean single-name buy, but the size is limited. The main watch item is whether this is a one-off consumer-tech add or the start of broader large-cap tech accumulation.
This was a broad selling filing: the largest 6 of 28 disclosed trades include full or partial sales of PG, HD, MDT, MSFT, HONA and ICLR, with the two largest lines each in the $50,001 - $100,000 range.
The size and breadth matter more than any one ticker: this reads like portfolio de-risking rather than a single-stock view. Hern’s filing is the largest congressional disclosure in the dataset by a wide margin.
| PG | Sell | STOCK | $50,001 - $100,000 |
| HD | Sell | STOCK | $50,001 - $100,000 |
| MDT | Sell | STOCK | $15,001 - $50,000 |
| MSFT | Sell | STOCK | $15,001 - $50,000 |
| HONA | Sell | STOCK | $15,001 - $50,000 |
| ICLR | Sell | STOCK | $15,001 - $50,000 |
Conifer Management reported an open-market purchase of 3,539 GPI shares at an average price of $269.6588, for a total value of about $954,322.
This is the strongest insider signal in the feed because it is a real purchase, not a grant or option exercise. A 10% owner adding capital at this size is a higher-conviction tell than routine executive compensation filings.
Jenisch reported an open-market purchase of 10,000 AMRZ shares at $42.37 per share, totaling $423,700.
CEO open-market buying is one of the cleaner insider signals, especially when the buyer already owns a large stake. The post-transaction ownership of 1,751,000 shares suggests this was an incremental conviction add, not a starter position.
Nichol reported a purchase of 2,000,000 DYNR shares; the parsed filing data does not include a price per share or total dollar value.
The share count is enormous, but the missing price makes the economic signal harder to rank. Still, a 10% owner increasing to 7,425,768 shares is worth monitoring for control or financing implications.
Mehra reported a sale of 3,266 MA shares at $584.00 per share, totaling $1,907,344, with 36,650.083 shares owned after the transaction.
This is the largest dollar-value insider sale in the feed. Sales can be routine, but the size makes it relevant for a mega-cap payments name trading on durable quality-premium assumptions.
Davis reported a sale of 17,557 BMRN shares at an average price of $66.284, for total proceeds of about $1,163,748.
The transaction is a meaningful executive sale in a biotech where regulatory and pipeline timing can move the stock sharply. It is not as strong a signal as an open-market buy, but the size puts it in the top tier of the day’s Form 4 activity.
| Company / Issuer | Filed | Source |
|---|---|---|
| CORCEPT THERAPEUTICS INC | 2026-09-03 | EDGAR ↗ |
| CORCEPT THERAPEUTICS INC | 2026-09-03 | EDGAR ↗ |
| CORCEPT THERAPEUTICS INC | 2026-09-03 | EDGAR ↗ |
| CORCEPT THERAPEUTICS INC | 2026-09-03 | EDGAR ↗ |
| GROUP 1 AUTOMOTIVE INC | 2026-09-03 | EDGAR ↗ |
| CORCEPT THERAPEUTICS INC | 2026-09-03 | EDGAR ↗ |
| CORCEPT THERAPEUTICS INC | 2026-09-03 | EDGAR ↗ |
| Borr Drilling Ltd | 2026-09-03 | EDGAR ↗ |
| Viper Energy, Inc. | 2026-09-03 | EDGAR ↗ |
| Fold Holdings, Inc. | 2026-09-03 | EDGAR ↗ |
The company entered securities purchase agreements to sell 103,109,005 common shares for gross proceeds of approximately $26.2 million, at $0.2541 per share, with proceeds for working capital and general corporate purposes.
The risk is dilution: the filing ties a very large share issuance to a sub-dollar stock price and requires a resale registration statement by Oct. 2, 2026. Affiliate investors are participating, which helps funding optics but does not remove the overhang from newly issued shares.
Crown PropTech and CIIG Management entered eight non-redemption agreements with BlackRock-managed funds covering 400,000 public shares, expected to retain at least $4.8 million in trust against a $5.0 million minimum cash condition.
The buried risk is fragility: the filing says the agreements are not expected to increase the likelihood of shareholder approval, only the funds remaining after redemptions. That makes cash leakage and deal-close mechanics the key watch items.
The company amended and restated its merger agreement with Remix Therapeutics to provide for a two-step merger: first into Merger Sub, then immediately into Merger Sub II, with Remix becoming a wholly owned subsidiary structure through the transaction.
The structural rewrite is the signal, especially alongside Item 3.02 unregistered securities disclosure. Investors should watch whether the revised terms change dilution, tax treatment or closing certainty versus the original June 24 agreement.
Apogee agreed to acquire 100% of SIA Alzette, which owns Groglass, for a transaction value of approximately €62.5 million on a cash-free, debt-free basis, including contingent consideration; the maximum earnout is €10 million over three years.
The deal adds advanced glass coating technology but brings integration and financing risk. Apogee plans to fund the transaction with cash on hand and borrowings under its existing credit facility, so leverage and synergy execution are the watch items.
The filing references a Note Purchase Agreement dated Sept. 2, 2026 and incorporates a Sixth Supplemental Indenture relating to 7.50% Notes due 2029; the excerpt does not provide the principal amount or full covenant terms.
For a credit-oriented issuer, incremental 7.50% debt is a funding-cost and leverage signal. The risk is buried in the exhibit list and Item 2.03 cross-reference, so the next step is reading the note purchase agreement for size, covenants and use of proceeds.
| Company / Issuer | Filed | Source |
|---|---|---|
| EQUITY BANCSHARES INC (EQBK) | 2026-09-03 | EDGAR ↗ |
| Ribbon Acquisition Corp. (RIBB, RIBBR, RIBBU) | 2026-09-03 | EDGAR ↗ |
| BANK5 2026-5YR23 | 2026-09-03 | EDGAR ↗ |
| BANK5 2026-5YR23 | 2026-09-03 | EDGAR ↗ |
| BANK5 2026-5YR23 | 2026-09-03 | EDGAR ↗ |
| BANK5 2026-5YR23 | 2026-09-03 | EDGAR ↗ |
| Texas Ventures Acquisition III Corp (TVA, TVACU, TVACW) | 2026-09-03 | EDGAR ↗ |
| Ribbon Acquisition Corp. (RIBB, RIBBR, RIBBU) | 2026-09-03 | EDGAR ↗ |
| AAPL | $328.21 | +0.17% |
| MSFT | $510.12 | +0.10% |
| NVDA | $228.45 | -0.51% |
| AMZN | $258.90 | -0.14% |
| GOOGL | $342.48 | -0.13% |
| META | $610.68 | -0.52% |
| TSLA | $376.37 | +0.46% |
| NFLX | $82.67 | +0.54% |
| JPM | $362.06 | -0.05% |
| AMD | $456.16 | +0.24% |
| MSTR | +17.6% | $144.82 |
| SMMT | +17.3% | $17.13 |
| HCM | +17.2% | $14.11 |
| HOOD | +16.6% | $124.72 |
| SNOW | +16.6% | $356.47 |
| CRCL | +16.5% | $103.23 |
| BMNR | +14.7% | $26.45 |
| CIFR | +14.4% | $17.37 |
| RIOT | +13.4% | $21.14 |
| PURR | +12.8% | $12.77 |
| CLS | +11.6% | $309.84 |
| XXI | +11.5% | $6.40 |
| HSAI | +11.3% | $18.46 |
| BULL | +11.1% | $10.00 |
| CLSK | +11.0% | $12.58 |
| BLSH | +11.0% | $36.22 |
| BTDR | +10.9% | $11.91 |
| MARA | +10.8% | $11.60 |
| ASST | +10.3% | $26.82 |
| GLXY | +10.1% | $26.50 |
| PSQL | -20.0% | $9.75 |
| VSXY | -13.2% | $73.64 |
| CIEN | -10.4% | $317.46 |
| PL | -8.2% | $18.35 |
| TSN | -7.3% | $51.76 |
| CPB | -7.0% | $22.12 |
| AMR | -6.9% | $217.18 |
| LIME | -6.7% | $38.83 |
| LKNCY | -6.5% | $33.96 |
| WIX | -6.3% | $81.20 |
| BTU | -6.1% | $27.64 |
| TDW | -6.0% | $94.58 |
| AMBA | -5.6% | $63.38 |
| HP | -5.5% | $45.02 |
| IONS | -5.2% | $58.13 |
| MZTI | -5.2% | $105.64 |
| TCOM | -5.1% | $41.40 |
| CNR | -5.1% | $97.43 |
| AEHR | -5.0% | $76.27 |
| CVSA | -4.9% | $127.64 |